Search results

iResponse is an AI-driven digital health platform designed to implement preventive health diagnostics, improve patient care, send out early warning and alert notification, track, predict, analyse and deal with COVID-19 infectious disease threat in Nigeria.
It helps better the human condition and bring about a better future to Nigerians using Artificial Intelligence (AI), big data analytics and digital technologies to manage and quarantine the exposed person, and deal with the pandemic in Nigeria.

Avril Biopharma’s main focus is rapid development of diagnostic, vaccine and therapeutic products using bioinformatics to design these products and our AdCEV(TM) protein expression technology to produce them inexpensively in hen eggs.
We are using our platform to address the urgent public-health demand for COVID-19 diagnostic testing and safe vaccine production. We are developing simple point-of-care test-kit products including a 5-10 minute saliva test for SARS-CoV-2 infection using components we can make in hen eggs. With our high yields, enough material for thousands of individual tests

Africa is highly vulnerable to the current COVID-19 pandemic. While several vaccine and antiviral candidates to prevent
COVID-19 infection are currently under development, they most likely will be expensive, difficult to transport
and distribute to remote areas and not available in sufficient quantities to administer to everyone.
Our solution is to use a plant production platform to generate vaccines, antiviral drugs and other pharmaceutical proteins. We use
our production platform to rapidly make safe vaccines which are stable at ambient temperatures, easy to scale up
and inexpensive

The National Public Health Laboratory (NPHL) is the nerve center of the Gambia’s national anti-covid19 strategy. In recent weeks we have worked closely with colleagues at the MRC Unit the Gambia at LSHTM to develop COVID-19 diagnostic testing capacity at NPHL. As a COVID-19 testing center we can contribute towards increasing national testing capacity. However, with only two testing centers in the Gambia and limited resources to meet the potential demand for high numbers of tests, there is a dire need to explore innovative solutions for scaling up COVID-19 testing capacity in a short space of

Violence in families, including violence against children, and women are increasing in an alarming rate during COVID-19 pandemic-induced lockdown. This initiative will implement and evaluate parenting information dissemination, and interactive learning via facilitated parent-support group-based online discussions using text, audio, video, and visual messages. It aims to provide real-time access to parenting information, and interventions to reduce family violence while improving parent-child relationships and child wellbeing. Evidence-based parenting for lifelong health information (PLH) which

Although SARS-CoV-2 diagnostic tests such as RT-PCR are the gold standard to confirm COVID-19, demand for PCR test-kits is extremely high and many countries face capacity limitations in the resources involved, thus timely access to rapid testing and diagnosis is critical. CT imaging has shown to be a highly sensitive method to detect COVID-19, however, availability of CT imaging is limited in developing countries. Alternatively, X-ray is also used among patients presenting COVID-19 symptoms, and although it is not as sensitive as CT, X-ray uses less radiation and is often less expensive